Loading...
SIGA Technologies, Inc.
SIGA•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$7.14
$0.08(1.13%)
SIGA Technologies, Inc. (SIGA) Financial Performance & Income Statement Overview
Review SIGA Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.86%
↓ 0.86%
Operating Income Growth
54.86%
↑ 54.86%
Net Income Growth
-13.01%
↓ 13.008%
Operating Cash Flow Growth
-48.56%
↓ 48.56%
Operating Margin
46.91%
↑ 46.91%
Gross Margin
70.89%
↑ 70.89%
Net Profit Margin
40.33%
↑ 40.33%
ROE
25.24%
↑ 25.24%
ROIC
25.75%
↑ 25.75%
SIGA Technologies, Inc. (SIGA) Income Statement & Financial Overview
Review SIGA Technologies, Inc.'s (SIGA) income statement with detailed quarterly and annual figures.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $10.010M | $21.81M | $25.43M | $116.48M |
| Cost of Revenue | $1.62M | $12.31M | $3.23M | $14.80M |
| Gross Profit | $8.39M | $9.50M | $22.20M | $101.68M |
| Gross Profit Ratio | $0.84 | $0.44 | $0.87 | $0.87 |
| R&D Expenses | $1.07M | $2.89M | $3.05M | $2.62M |
| SG&A Expenses | $4.82M | $5.53M | $7.88M | $7.38M |
| Operating Expenses | $7.85M | $8.42M | $10.93M | $10.00M |
| Total Costs & Expenses | $9.47M | $20.73M | $14.15M | $24.80M |
| Interest Income | $0.00 | $0.00 | $0.00 | $1.19M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $890629.00 |
| Depreciation & Amortization | $0.00 | $140839.00 | $138471.00 | $137591.00 |
| EBITDA | $542087.00 | $1.22M | $11.41M | $91.81M |
| EBITDA Ratio | $0.05 | $0.06 | $0.45 | $0.79 |
| Operating Income | $542087.00 | $1.08M | $11.28M | $91.68M |
| Operating Income Ratio | $0.05 | $0.05 | $0.44 | $0.79 |
| Other Income/Expenses (Net) | $1.33M | $1.32M | $1.94M | $1.19M |
| Income Before Tax | $1.87M | $2.40M | $13.22M | $92.87M |
| Income Before Tax Ratio | $0.19 | $0.11 | $0.52 | $0.80 |
| Income Tax Expense | $528647.00 | $565219.00 | $2.94M | $20.61M |
| Net Income | $1.34M | $1.83M | $10.28M | $72.26M |
| Net Income Ratio | $0.13 | $0.08 | $0.40 | $0.62 |
| EPS | $0.02 | $0.03 | $0.14 | $1.02 |
| Diluted EPS | $0.02 | $0.03 | $0.14 | $1.02 |
| Weighted Avg Shares Outstanding | $71.37M | $71.15M | $71.09M | $71.09M |
| Weighted Avg Shares Outstanding (Diluted) | $71.77M | $71.75M | $71.56M | $71.09M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan